AGL:NYE-agilon health Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 4.2

Change

+0.15 (+3.70)%

Market Cap

USD 1.67B

Volume

8.25M

Analyst Target

N/A
Analyst Rating

Sell

ducovest Verdict
Created with Highstock 5.0.6

Bearish

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
AGL VTI
  • VTI
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+1.70 (+0.52%)

USD 79.32B
DVA DaVita HealthCare Partners Inc

+0.13 (+0.09%)

USD 12.59B
THC Tenet Healthcare Corporation

-2.67 (-2.09%)

USD 12.13B
UHS Universal Health Services Inc

+1.76 (+1.01%)

USD 11.22B
EHC Encompass Health Corp

-0.11 (-0.11%)

USD 10.00B
CHE Chemed Corp

-1.77 (-0.29%)

USD 8.72B
CON Concentra Group Holdings Paren..

-0.24 (-1.14%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

+0.18 (+1.28%)

USD 2.59B
NHC National HealthCare Corporatio..

+0.21 (+0.23%)

USD 1.90B
GRDN Guardian Pharmacy Services, In..

+0.65 (+3.16%)

USD 1.25B

ETFs Containing AGL

XHS SPDR® S&P Health Care Se.. 2.86 % 0.35 %

+0.12 (+0.38%)

USD 0.08B
MVW:AU VanEck Vectors Australian.. 1.44 % 0.00 %

+0.14 (+0.38%)

USD 2.68B
OPEN:F iShares VI Public Limited.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 121.05% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 121.05% 100% F 100% F
Trailing 12 Months  
Capital Gain -22.22% 18% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.22% 18% F 11% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -28.77% 5% F 1% F
Dividend Return -28.77% 5% F 1% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 32.87% 68% D+ 31% F
Risk Adjusted Return -87.53% 9% A- 1% F
Market Capitalization 1.67B 57% F 65% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector